• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Appropriate knowledge of HPV vaccine important for uptake among college-age young adults

byConstance Wu
October 6, 2020
in StudyGraphics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Among a cohort of college-age young adults, having appropriate knowledge of the HPV vaccine was associated with increased uptake, while high uncertainty was associated with decreased uptake.

Evidence Rating Level: 2 (Good)

Study Rundown: Human papillomavirus (HPV) is the most common sexually transmitted infection in the U.S., and can lead to numerous health concerns, including cancers of the cervix, penis, anus, and oropharynx. The HPV vaccination can prevent over 90% of HPV-related cancers; as such, the Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination for everyone aged 9 to 26. Uptake, however, is low, with only 48.6% of adolescents aged 13 to 17 up to date with the recommended series as of 2017. Much of this stems from parental attitudes towards and understanding of the HPV vaccine. Thus, this study explored college students’ knowledge of, attitudes towards, and beliefs regarding uptake of the HPV vaccine, since these students aged 18 to 26 can make their own decisions regarding vaccination.

Students from a Southern California state university were asked to complete a questionnaire that recorded demographic information; outcome variables of having received HPV vaccination in the past and/or intention to receive the vaccine in the next six months; and overall knowledge, attitudes, and beliefs regarding HPV vaccination. The modified Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) was used utilized. It was found that, overall, there was no significant difference in the level of HPV knowledge across the three outcome groups (i.e. those vaccinated, those intending to be vaccinated, and those not intending to be vaccinated). However, the overall level of HPV vaccine knowledge was higher among students who were previously vaccinated. In a regression analysis, knowledge of the HPV vaccine was found to be associated with increased vaccine uptake, while a high level of uncertainty was inversely associated with uptake.

This study is limited by a sample drawn exclusively from a college environment. Additionally, 85.1% and 91.2% of participants identified as female and heterosexual, respectively, while 86.7% of participants had health insurance. Furthermore, 36.5% identified as Hispanic, which is higher than the 26% of the general population aged 16 to 33 that identifies as such. These demographic data may limit this study’s generalizability. Overall, this study has important public health implications by identifying discrete areas of intervention, such as enhancing education to reduce uncertainty, that may help increase HPV vaccine uptake among young adults.

Click here to read the study in the Journal of Community Health

Relevant reading: Knowledge and Awareness of Human Papillomavirus Among College Students in South Carolina

RELATED REPORTS

Imiquimod noninferior to surgery in management of vulvar high-grade squamous intraepithelial lesions

Persistent human papillomavirus infection during pregnancy significantly associated with preterm birth

Increasing vaccine coverage in low and middle-income countries may prevent over 30 million deaths between 2020 to 2030

In-depth [qualitative cross-sectional study]: A total of 181 college students (mean [SD] age = 21.4 [2.22] years) completed the questionnaire. Among them, 101 (55.8%) had received at least one dose of the HPV vaccine, 52 (28.7%) intended to receive the vaccine, and 28 (15.5%) did not intend to receive the vaccine. This is far lower than the Healthy People target goal of 80% coverage for those aged 13 to 15. Knowledge concerning HPV did not differ significantly between the three outcome groups, but knowledge concerning the HPV vaccine was higher among those who had previously received the vaccine. In multivariate logistic regression, a higher level of HPV vaccine knowledge was most strongly associated with vaccine uptake (OR 1.17, 95% CI 1.06 to 1.28, p = 0.002). Conversely, a higher level of uncertainty was inversely associated with vaccine uptake (OR 0.62, 95% CI 0.41 to 0.93, p = 0.02). Finally, gender, race, religion, and having health insurance had no impact on HPV vaccine uptake in regression analysis.

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: hpvhpv vaccine
Previous Post

Early introduction of gluten to infants associated with a lower incidence of celiac disease

Next Post

Early changes in albuminuria with Canagliflozin predicts kidney and cardiovascular outcomes

RelatedReports

Chronic Disease

Imiquimod noninferior to surgery in management of vulvar high-grade squamous intraepithelial lesions

May 17, 2022
Reduced HPV vaccine doses may be adequate
Infectious Disease

Persistent human papillomavirus infection during pregnancy significantly associated with preterm birth

September 21, 2021
Preterm infants responsive to PCV13 vaccine
Public Health

Increasing vaccine coverage in low and middle-income countries may prevent over 30 million deaths between 2020 to 2030

June 25, 2021
Compliance-linked incentives increase infant immunizations rates in rural India
Infectious Disease

Appropriate knowledge of HPV vaccine important for uptake among college-age young adults

September 26, 2020
Next Post
2 Minute Medicine Rewind October 14, 2019

Early changes in albuminuria with Canagliflozin predicts kidney and cardiovascular outcomes

#VisualAbstract: Sarcopenia associated with reduced muscle mass and strength following liver resection for malignant neoplasms

#VisualAbstract: COVID-19 associated with cardiac manifestations in pediatric patients

Peanut allergy effectively treated with oral immunotherapy: the PALISADE trial

Halloween and Easter associated with increased rates of anaphylaxis in Canadian pediatric patients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir
  • Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial
  • #VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.